Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
American Journal of Clinical Oncology
|
January 6, 2022
Patterns of Care in Maintenance Therapy in US Patients Undergoing Definitive Chemoradiation for Stage 3 Non-Small Cell Lung Cancer (NSCLC)
Jason Liu, Emily Bratton, Xinyan Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2004
Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition
David R Gandara, Howard West, Kari Chansky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2005
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study
Fred R Hirsch, Marileila Varella-Garcia, Jason McCoy, et al.
Cancers
|
August 26, 2022
Ablative Radiotherapy as a Strategy to Overcome TKI Resistance in EGFR-Mutated NSCLC
Jennifer Novak, Ravi Salgia, Howard West, et al.
Journal of Personalized Medicine
|
September 28, 2023
Pancreatic Adenocarcinoma: Real World Evidence of Care Delivery in AccessHope Data
Afsaneh Barzi, Angela J Kim, Crystal K Liang, et al.
Cancer Chemotherapy and Pharmacology
|
March 30, 2017
A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer
Heather A Wakelee, Scott Gettinger, Jeffrey Engelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma
Mark G Kris, Giuseppe Giaccone, Angela Davies, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 30, 2014
A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non-small-cell lung cancer
D Ross Camidge, Eamon M Berge, Robert C Doebele, et al.
ESMO Open
|
July 19, 2018
Patient-reported outcomes in a phase II, North American study of alectinib in patients with <i>ALK</i>-positive, crizotinib-resistant, non-small cell lung cancer
Sai-Hong Ignatius Ou, Mark A Socinski, Shirish Gadgeel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 4, 2006
Phase I Trial of sequential administration of recombinant DNA and adenovirus expressing L523S protein in early stage non-small-cell lung cancer
John Nemunaitis, Thomas Meyers, Neil Senzer, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
American Journal of Clinical Oncology
|
January 6, 2022
Patterns of Care in Maintenance Therapy in US Patients Undergoing Definitive Chemoradiation for Stage 3 Non-Small Cell Lung Cancer (NSCLC)
Jason Liu, Emily Bratton, Xinyan Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2004
Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition
David R Gandara, Howard West, Kari Chansky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2005
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study
Fred R Hirsch, Marileila Varella-Garcia, Jason McCoy, et al.
Cancers
|
August 26, 2022
Ablative Radiotherapy as a Strategy to Overcome TKI Resistance in EGFR-Mutated NSCLC
Jennifer Novak, Ravi Salgia, Howard West, et al.
Journal of Personalized Medicine
|
September 28, 2023
Pancreatic Adenocarcinoma: Real World Evidence of Care Delivery in AccessHope Data
Afsaneh Barzi, Angela J Kim, Crystal K Liang, et al.
Cancer Chemotherapy and Pharmacology
|
March 30, 2017
A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer
Heather A Wakelee, Scott Gettinger, Jeffrey Engelman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma
Mark G Kris, Giuseppe Giaccone, Angela Davies, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 30, 2014
A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non-small-cell lung cancer
D Ross Camidge, Eamon M Berge, Robert C Doebele, et al.
ESMO Open
|
July 19, 2018
Patient-reported outcomes in a phase II, North American study of alectinib in patients with <i>ALK</i>-positive, crizotinib-resistant, non-small cell lung cancer
Sai-Hong Ignatius Ou, Mark A Socinski, Shirish Gadgeel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 4, 2006
Phase I Trial of sequential administration of recombinant DNA and adenovirus expressing L523S protein in early stage non-small-cell lung cancer
John Nemunaitis, Thomas Meyers, Neil Senzer, et al.
Page
of 5